Cytokine-induced killer cells (CIKs) were recognized in the 1990s, and investigations demonstrated that CIKs may serve in a novel treatment of cancers, including ovarian cancer (87, 88). The gene discussed is TRAF3IP2; the disease is ovarian carcinoma.